Dirk Moritz

1.7k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Dirk Moritz is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Dirk Moritz has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Dirk Moritz's work include Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (5 papers) and Mast cells and histamine (3 papers). Dirk Moritz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (5 papers) and Mast cells and histamine (3 papers). Dirk Moritz collaborates with scholars based in Switzerland, Germany and United States. Dirk Moritz's co-authors include Bernd Groner, R Klemenz, Bing Li, Xiao Liang, Jennifer LeCouter, Gail D. Lewis Phillips, Hans‐Peter Gerber, Napoleone Ferrara, Kenneth J. Hillan and Winfried S. Wels and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Dirk Moritz

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1

2003 513 citations Jennifer LeCouter, Dirk Moritz et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dirk Moritz Switzerland	14	518	511	441	276	246	15	1.4k
Josef Mysliwietz Germany	18	478 0.9×	540 1.1×	636 1.4×	295 1.1×	36 0.1×	47	1.7k
D. Ockert Germany	15	345 0.7×	582 1.1×	358 0.8×	212 0.8×	142 0.6×	47	1.2k
Catherine Sibille Belgium	18	577 1.1×	280 0.5×	443 1.0×	392 1.4×	141 0.6×	30	1.3k
Bart Jonckx Belgium	15	324 0.6×	426 0.8×	961 2.2×	141 0.5×	187 0.8×	24	1.8k
Lise Boussemart France	11	261 0.5×	722 1.4×	830 1.9×	254 0.9×	211 0.9×	17	1.6k
D Liénard Switzerland	13	1.1k 2.1×	861 1.7×	978 2.2×	123 0.4×	53 0.2×	20	2.1k
Thomas U. Marron United States	17	766 1.5×	520 1.0×	337 0.8×	60 0.2×	205 0.8×	87	1.4k
Laura K. Aguilar United States	22	537 1.0×	791 1.5×	444 1.0×	88 0.3×	119 0.5×	45	1.5k
Luigi P. Ruco Italy	9	962 1.9×	735 1.4×	420 1.0×	78 0.3×	75 0.3×	11	1.6k
Brian Cao United States	17	92 0.2×	381 0.7×	638 1.4×	131 0.5×	342 1.4×	37	1.2k

Countries citing papers authored by Dirk Moritz

Since Specialization

Citations

This map shows the geographic impact of Dirk Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Moritz more than expected).

Fields of papers citing papers by Dirk Moritz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Moritz. The network helps show where Dirk Moritz may publish in the future.

Co-authorship network of co-authors of Dirk Moritz

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Moritz. A scholar is included among the top collaborators of Dirk Moritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Moritz. Dirk Moritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

LeCouter, Jennifer, Dirk Moritz, Bing Li, et al.. (2003). Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1. Science. 299(5608). 890–893. 513 indexed citations breakdown →

Wyder, Lorenza, Alessandra Vitaliti, Henriette Schneider, et al.. (2000). Increased expression of H/T-cadherin in tumor-penetrating blood vessels.. PubMed. 60(17). 4682–8. 65 indexed citations

Moritz, Dirk, Jacqueline Gheyselinck, & R Klemenz. (1998). Expression Analysis of the Soluble and Membrane-Associated Forms of the Interleukin-1 Receptor-Related Tl Protein in Primary Mast Cells and Fibroblasts. Hybridoma. 17(2). 107–116. 17 indexed citations

Moritz, Dirk, et al.. (1998). GATA-Dependent Expression of the Interleukin-1 Receptor-Related T1 Gene in Mast Cells. Molecular and Cellular Biology. 18(9). 5320–5331. 28 indexed citations

Moritz, Dirk, Hans-Reimer Rodewald, Jacqueline Gheyselinck, & R Klemenz. (1998). The IL-1 Receptor-Related T1 Antigen Is Expressed on Immature and Mature Mast Cells and on Fetal Blood Mast Cell Progenitors. The Journal of Immunology. 161(9). 4866–4874. 195 indexed citations

Altenschmidt, Uwe, Dirk Moritz, & Bernd Groner. (1997). Specific cytotoxic T lymphocytes in gene therapy. Journal of Molecular Medicine. 75(4). 259–266. 30 indexed citations

Altenschmidt, Uwe, Dirk Moritz, Barbara S. Schnierle, et al.. (1996). Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.. PubMed. 2(6). 1001–8. 65 indexed citations

Schnierle, Barbara S., Dirk Moritz, Marc G. Jeschke, & Bernd Groner. (1996). Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.. PubMed. 3(4). 334–42. 42 indexed citations

Hekele, Armin, Peter Dall, Dirk Moritz, et al.. (1996). Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimera. International Journal of Cancer. 68(2). 232–238. 46 indexed citations

10.

Wels, Winfried S., Dirk Moritz, Mathias Schmidt, et al.. (1995). Biotechnological and gene therapeutic strategies in cancer treatment. Gene. 159(1). 73–80. 25 indexed citations

11.

Gouilleux, Fabrice, Dirk Moritz, Matjaž Humar, et al.. (1995). Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor.. Endocrinology. 136(12). 5700–5708. 62 indexed citations

12.

Moritz, Dirk & Bernd Groner. (1995). A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.. PubMed. 2(8). 539–46. 77 indexed citations

13.

Moritz, Dirk, Winfried S. Wels, J Mattern, & Bernd Groner. (1994). Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.. Proceedings of the National Academy of Sciences. 91(10). 4318–4322. 169 indexed citations

14.

Lindemann, Dirk, et al.. (1990). Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Research. 18(1). 9–20. 22 indexed citations

15.

Moritz, Dirk, et al.. (1990). CD4‐affinity purification of recombinant and native HIV gp 120 and comparison of the affinity constants for the receptor. FEBS Letters. 275(1-2). 146–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact